4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
REGENXBIO Inc. (RGNX) operates in the Biotechnology industry and is headquartered in Rockville, United States with about 371 employees. Its market capitalization is roughly $607 million. In the fiscal year ended 2025-12-31, RGNX reported $170M in revenue and ($194M) in net income.
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform.
Interactive charts & full statements → Open the RGNX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $170M | $83M | $90M | $113M | — |
| Gross Profit | $150M | $50M | $53M | $58M | — |
| Operating Income (EBIT) | ($161M) | ($231M) | ($268M) | ($263M) | — |
| Net Income | ($194M) | ($227M) | ($264M) | ($280M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $108M | $6M | $30M | $30M | $21M | — | — |
| Gross Profit | $107M | ($5M) | $24M | $24M | $16M | — | — |
| Operating Income (EBIT) | $29M | ($83M) | ($58M) | ($52M) | ($63M) | — | — |
| Net Income | $23M | ($90M) | ($67M) | ($62M) | ($71M) | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $453M | $466M | $574M | $833M | — |
| Total Liabilities | $350M | $206M | $262M | $317M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RGNX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms